07 New or worsening headaches Especially with visual symptoms, this can mirror intracranial hypertension reported in the Increlex label
The DRI modification that stabilizes the peptide against degradation also means its elimination kinetics in humans are unknown
For a 5mg vial: Add 2.5ml bacteriostatic water Resulting concentration: 2mg/ml (2000mcg/ml) For a 100mcg dose: draw 0.05ml (5 units on a standard insulin syringe) For a 200mcg dose: draw 0.10ml (10 units) For a 10mg vial: Add 3.0ml bacteriostatic water Resulting concentration: 3.33mg/ml (3333mcg/ml) For a 100mcg dose: draw 0.03ml (3 units) For a 200mcg dose: draw 0.06ml (6 units) Alternatively, for easier math with a 5mg vial, you can add 5ml of bacteriostatic water to create a 1mg/ml (1000mcg/ml) concentration
Children presenting neurological signs or symptoms, those unable to take oral medication, individuals with known malabsorption syndromes, infants under 6 months old, and patients using medications that may interfere with vitamin B12 absorption are typically treated with a parenteral protocol (1)
Time: 15 mins We want to ensure you have all the information you need before booking your appointment
We have no data on human absorption, which is why usage protocols vary so much